Ipsos Health Service Report 2026 - Ipsos

Since 2018, Ipsos has been tracking perceptions of the quality of healthcare systems, the biggest health issues and the biggest public health problems. Key Research Findings:Download the report belowMental health remains the biggest health problem and is growing as a concernOn average across 32 countries one in two (48%) see mental health as one of the biggest health problems in their country ahead of cancer (40%), stress (32%) and obesity (25%). Mental health has topped our list of worries since 2023 and despite many already seeing it as a problem 19 out of the 28 countries surveyed this year and last are more likely to see it as major issue in 2026. Quality of care perceptions vary sharply around the world Malaysia tops our quality of care perceptions index with a score of 72%. While Hungary records the lowest score (28%). The quality of care perceptions index looks at people’s satisfaction with their country’s healthcare system, trust in the system, ability to access a doctor and a pharmacy, and whether the system treats all people equally.

Since 2018, Ipsos has been tracking perceptions of the quality of healthcare systems, the biggest health issues and the biggest public health problems. Key Research Findings:Download the report belowMental health remains the biggest health problem and is growing as a concernOn average across 32 countries one in two (48%) see mental health as one of the biggest health problems in their country ahead of cancer (40%), stress (32%) and obesity (25%). Mental health has topped our list of worries since 2023 and despite many already seeing it as a problem 19 out of the 28 countries surveyed this year and last are more likely to see it as major issue in 2026. Quality of care perceptions vary sharply around the world Malaysia tops our quality of care perceptions index with a score of 72%. While Hungary records the lowest score (28%). The quality of care perceptions index looks at people’s satisfaction with their country’s healthcare system, trust in the system, ability to access a doctor and a pharmacy, and whether the system treats all people equally.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.